title: Pancytopenia due to linezolid treatment.
abstract: Antibiotic-resistant infections constitute a significant portion of severe childhood infections. A gradually increasing resistance and treatment difficulty are observed in infections caused by enterococci, staphylococci and pneumococci. Linezolid is one of the new antibiotics which has recently been introduced for clinical use with gram positive efficiency. In this article, a pediatric patient with vancomycin-resistant enterococcus infection who developed reversible bone marrow supression related with use of linesolid was presented. A shunt was inserted in a ten-month old female patient who had been operated at the age of one month because of meningomyelocele and who had developed hydrocephalus. Linezolid and meropenem treatment was started when vancomycin-resistant Enterococcus faecium and extended-spectrum beta-lactamase positive Escherichia coli grew in cerebrospinal fluid culture. In the second week of treatment, cerebrospinal fluid findings improved. However, bone marrow supression was observed. Linezolid treatment was discontinued. In the follow-up, the blood cell counts returned to normal levels.
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Atatürk University Faculty of Medicine, Erzurum, Turkey.
authors.forename: Emine
authors.initials: E
authors.lastname: Parlak
authors.affiliation: Department of Pediatrics, Division of Pediatric Neurology, Atatürk University Faculty of Medicine, Erzurum, Turkey.
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Tan
keywords: Enterococcus; linezolid; pancytopenia; shunt infection